On October 13, PHARMARON fell 3.41% in regular trading, trading at 29.4 Hong Kong dollars, with Turnover of 31.858 million Hong Kong dollars. The stock was pressured by the latest development in a shareholder inquiry transfer.

The company disclosed that a pricing of 38.89 yuan per share had been preliminarily set for a planned transfer of 18.373 million shares by Pharmaron Holdings Limited, an offshore employee stock ownership platform. The transfer was reportedly for the shareholder's own funding needs, with the shares being fully subscribed by 13 institutional investors. The price represented a discount of about 6.96% to the closing price of 41.8 yuan on October 12. The transferred shares are subject to a six-month lock-up period after registration.

This transaction follows a September 14 rally when the sector rose broadly on strong mid-year results and sector upgrades. The current pullback, however, reflects immediate pressure from the discounted share placement rather than a change in underlying industry fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)